Principal Nutrition Limited 31/03/2025 iXBRL

Company registration number: 12166180

Principal Nutrition Limited

Unaudited filleted financial statements

31 March 2025

Principal Nutrition Limited

Contents

Directors and other information

Accountant's report

Statement of financial position

Statement of changes in equity

Notes to the financial statements

Principal Nutrition Limited

Directors and other information


	Director	Mr Yusuf Paterson-Mosafeer


	Company number	12166180


	Registered office	Unit 3, Armitage Business Park Private Road 3
		Colwick Industrial Estate
		Nottingham
		NG4 2TB


	Accountant	JSB Accountancy
		Unit 4 Brunel Business Park
		Jessop Close
		Newark
		Nottinghamshire
		NG24 2AG

Principal Nutrition Limited

Report to the director on the preparation of the

unaudited statutory financial statements of Principal Nutrition Limited

Period ended 31 March 2025

As described on the statement of financial position, the director of the company is responsible for the preparation of the financial statements for the period ended 31 March 2025 which comprise the statement of financial position, statement of changes in equity and related notes.

You consider that the company is exempt from an audit under the Companies Act 2006. In accordance with your instructions I have compiled these unaudited financial statements in order to assist you to fulfil your statutory responsibilities, from the accounting records and from information and explanations supplied to me.

JSB Accountancy

ACCA

Unit 4 Brunel Business Park

Jessop Close

Newark

Nottinghamshire

NG24 2AG

15 December 2025

Principal Nutrition Limited

Statement of financial position

31 March 2025

		31/03/25		31/08/24
	Note	£	£	£	£

Current assets
Debtors		30,100		-
Cash at bank and in hand		22,606		46,014
		_______		_______
		52,706		46,014
Creditors: amounts falling due
within one year		( 9,754)		( 6,868)
		_______		_______
Net current assets			42,952		39,146
			_______		_______
Total assets less current liabilities			42,952		39,146

			_______		_______
Net assets			42,952		39,146
			_______		_______

Capital and reserves
Called up share capital			100		100
Profit and loss account			42,852		39,046
			_______		_______
Shareholder funds			42,952		39,146
			_______		_______

For the period ending 31 March 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Director's responsibilities:

- The member has not required the company to obtain an audit of its financial statements for the period in question in accordance with section 476;

- The director acknowledges their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.

These financial statements were approved by the board of directors and authorised for issue on 15 December 2025 , and are signed on behalf of the board by:

Mr Yusuf Paterson-Mosafeer

Director

Company registration number: 12166180

Principal Nutrition Limited

Statement of changes in equity

Period ended 31 March 2025

	Called up share capital	Profit and loss account	Total
	£	£	£


At 1 September 2023	100	28,768	28,868

Profit for the period		10,278	10,278
	_______	_______	_______
Total comprehensive income for the period	-	10,278	10,278

	_______	_______	_______
At 31 August 2024 and 1 September 2024	100	39,046	39,146

Profit for the period		4,306	4,306
	_______	_______	_______
Total comprehensive income for the period	-	4,306	4,306

Dividends paid and payable		( 500)	( 500)
	_______	_______	_______
Total investments by and distributions to owners	-	( 500)	( 500)

	_______	_______	_______
At 31 March 2025	100	42,852	42,952
	_______	_______	_______

Principal Nutrition Limited

Notes to the financial statements

Period ended 31 March 2025

1. Statement of compliance

These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.

2. Accounting policies

Basis of preparation

The financial statements have been prepared on the historical cost basis, as modified by the revaluation of certain financial assets and liabilities and investment properties measured at fair value through profit or loss.

The financial statements are prepared in sterling, which is the functional currency of the entity.

Turnover

Turnover is measured at the fair value of the consideration received or receivable for goods supplied and services rendered, net of discounts and Value Added Tax.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Taxation

The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Tax is recognised in the statement of comprehensive income, except to the extent that it relates to items recognised in other comprehensive income or directly in capital and reserves. In this case, tax is recognised in other comprehensive income or directly in capital and reserves, respectively. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date.

Deferred tax is recognised in respect of all timing differences at the reporting date. Unrelieved tax losses and other deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.

Financial instruments

A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument. Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Debt instruments are subsequently measured at amortised cost. Where investments in non-convertible preference shares and non-puttable ordinary shares or preference shares are publicly traded or their fair value can otherwise be measured reliably, the investment is subsequently measured at fair value with changes in fair value recognised in profit or loss. All other such investments are subsequently measured at cost less impairment. Other financial instruments, including derivatives, are initially recognised at fair value, unless payment for an asset is deferred beyond normal business terms or financed at a rate of interest that is not a market rate, in which case the asset is measured at the present value of the future payments discounted at a market rate of interest for a similar debt instrument. Other financial instruments are subsequently measured at fair value, with any changes recognised in profit or loss, with the exception of hedging instruments in a designated hedging relationship.

Financial assets that are measured at cost or amortised cost are reviewed for objective evidence of impairment at the end of each reporting date. If there is objective evidence of impairment, an impairment loss is recognised in profit or loss immediately. For all equity instruments regardless of significance, and other financial assets that are individually significant, these are assessed individually for impairment. Other financial assets or either assessed individually or grouped on the basis of similar credit risk characteristics. Any reversals of impairment are recognised in profit or loss immediately, to the extent that the reversal does not result in a carrying amount of the financial asset that exceeds what the carrying amount would have been had the impairment not previously been recognised.

3. Directors advances, credits and guarantees

	During the period the director entered into the following advances and credits with the company:

Period ended 31/03/25
		Balance brought forward	Advances /(credits) to the director	Balance o/standing
		£	£	£
	Mr Yusuf Paterson-Mosafeer	( 3,657)	( 1,297)	( 4,954)
		_______	_______	_______

Year ended 31/08/24
		Balance brought forward	Advances /(credits) to the director	Balance o/standing
		£	£	£
	Mr Yusuf Paterson-Mosafeer	( 2,272)	( 1,385)	( 3,657)
		_______	_______	_______